A basis of the acanthocytosis in inherited and acquired disorders

P Wong1

  • 1Department of Oncology, McGill University, 546 Pine Avenue West, Montreal, Que., Canada H2W 1S6. pierre.wong@mcgill.ca

Medical Hypotheses
|May 15, 2004
PubMed

Insights

Acanthocytosis, a red blood cell shape change, is linked to Band 3 protein alterations. This study proposes a mechanism involving Band 3 conformation changes to explain acanthocytosis in various inherited and acquired disorders.

Area of Science:

  • Hematology
  • Cell Biology
  • Biochemistry

Background:

  • Acanthocytosis describes erythrocyte transformation into cells with irregular projections.
  • It is associated with diverse inherited and acquired conditions.
  • Previous work suggested a link between chorea-acanthocytosis and altered Band 3 protein.

Purpose of the Study:

  • To propose a mechanism for erythrocyte shape control involving Band 3 protein conformations.
  • To explain the occurrence of acanthocytosis in various disorders based on this mechanism.
  • To investigate the role of Band 3 conformation and membrane skeleton in erythrocyte shape determination.

Main Methods:

  • Proposed a model of erythrocyte shape control based on Band 3 outward-facing (Band 3(o)) and inward-facing (Band 3(i)) conformations.
  • Related the Band 3 conformation ratio to the Donnan equilibrium of anions and protons.
  • Analyzed evidence linking acanthocytosis to alterations in membrane skeleton and Band 3 properties across different conditions.

Main Results:

  • The proposed mechanism explains acanthocytosis in pyruvate kinase deficiency, pyrimidine 5'-nucleotidase deficiency, dehydrated hereditary stomatocytosis, In(Lu) phenotype, chorea-acanthocytosis, and McLeod phenotype via decreased Donnan ratio.
  • Alterations in membrane skeleton conformation are consistent with the proposed mechanism in chorea-acanthocytosis, McLeod phenotype, and Fanconi's anemia.
  • Acanthocytosis in Band 3 HT variant, chorea-acanthocytosis, In(Lu) phenotype, alcoholic cirrhosis, and abetalipoproteinemia supports the role of Band 3 conformation changes.

Conclusions:

  • Erythrocyte shape is significantly determined by Band 3 conformation and membrane skeleton status.
  • The proposed mechanism provides a unifying explanation for acanthocytosis in numerous disorders.
  • Lipid bilayer changes play a secondary role, with Band 3 conformation being the primary determinant of erythrocyte shape.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...